What Four Expert Investors Own Right Now $NVDA $AXON $CRWD $ASTS $RKLB $VOO (E134)
Four investors. Four wildly different portfolios. One crossover episode that gets uncomfortably honest about conviction, concentration, and whether the rules of investing have actually changed. Wall Street Wildlife’s Luke and Krzysztof team up with Bear and Drowsy from Shooting the Bull Pod — and the result is one of the most candid portfolio conversations we’ve ever recorded.
🤖 One investor is sitting on a 43% Nvidia position — and his defense of it might actually change your mind about concentration risk
🎯 Bear vs. Drowsy vs. Badger vs. Monkey: four real portfolios laid side-by-side, and the differences are stark — who’s right?
🌐 Has the Law of Large Numbers been repealed? $NVDA at $5T, Micron hitting $1T, Anthropic at $1T private — is gravity still a thing?
🧠 The trimming problem: why Bear sells too early, why Drowsy almost never sells, and the psychological trick that separates long-term winners from hyperactive traders
🚀 $RKLB and $ASTS under the microscope — are space stocks the real opportunity hiding in plain sight, or another 3D printing moment?
💀 A mea culpa on NeoClouds: Drowsy admits they “got it completely wrong” on Nebius — and what that confession reveals about investing humility $NBIS
🎓 Krzysztof’s evolution from quality-compounder to rock-flipper: the philosophical pivot that explains everything about his portfolio today
🌴 Dark horse stocks nobody’s talking about: Hinge Health, Oddity, MercadoLibre, Sterling Infrastructure, Palo Alto Networks — the roundtable gets spicy at the end $HNGE $ODD $MELI $STRL $PANW
Sources:
Shooting the Bull podcast: https://open.spotify.com/show/5qH1zzezA4EnHHGibgzJlb
Growth Stock Investing subreddit: https://www.reddit.com/r/GrowthStockInvesting/
Segments:
00:00:00 Four Investors, One Portfolio Showdown — The Crossover Begins
00:05:14 Golden Age of Individual Investing? AI, Community & the New Edge
00:07:54 Is This 2021 Again? What’s Different (and Scarier) About This Rally
00:15:19 Defending a 43% $NVDA Position — Drowsy Makes His Case
00:23:10 Portfolio Concentration Debate: Quality Giants vs. Rocks & Rubble
00:35:40 Krzysztof’s Confession: Why He Abandoned Blue-Chip Investing
00:43:03 $RKLB Sleep-at-Night Numbers & How Luke Actually Manages Risk
00:59:26 The Practical Trick That Stops You From Trading Too Much
01:05:00 $ASTS Deep Dive: Is Space the Most Overlooked Sector Right Now?
01:16:18 NeoClouds, Nebius & the Stocks They Got Wrong
01:20:01 Final Roundtable: One Stock Each That Deserves More Attention
Is This $2.4B Biotech About to Explode? + $MELI & $ISRG (E133)
Three stocks, three debates, one ticking clock. This week on Wall Street Wildlife, Krzysztof drops a live biotech catalyst with a 24-hour window, Luke defends his 20-year ‘sugar daddy’ holding, and a Latin American e-commerce giant is quietly being stress-tested. Plus: Krzysztof reveals a wild AI experiment he’s launching in
Four Stocks, Two Hosts, Zero Sugarcoating — Bull vs. Bear (E132)
Four companies. Two hosts. One brutal question: which stocks deserve your conviction right now, and which ones are just good stories hiding ugly fundamentals? This week, Luke and Krzysztof go bull-vs-bear on four names — and the conclusions might surprise you. The “too hard pile” is getting bigger, and maybe
Is $WISE About to Explode on the NASDAQ? (E131)
The largest UK fintech is abandoning the London Stock Exchange for the NASDAQ — and Luke thinks it could be an inflection point. This solo deep-dive makes the bull AND bear case on one of his highest-conviction holdings, right before the dual listing goes live. Here’s what every investor needs
The AI Math Is Brutal – Is Half Your Portfolio Already Dead? + $POET’s Wild Week (E130)
Luke sold two stocks this week. Not because earnings disappointed or guidance missed — but because he ran the numbers on what AI actually does to software valuations, and the math got uncomfortable fast. Meanwhile, Krzysztof turned a 70% options loss into a breakeven exit… then watched the stock moon
Is $NKTR the Most Undervalued Biotech Nobody’s Talking About? (E129)
200 million eczema sufferers. A leading drug that fails more than half of them. A cancer-causing alternative that still projects $5 billion in sales. And a tiny 60-person San Francisco biotech that may have cracked the code — with a Nobel Prize-validated mechanism the market is somehow pricing at near-zero.
Is AI Crushing Cybersecurity? $CRWD $PANW Face the Music (E128)
The AI arms race is here, and it’s shaking up the cybersecurity landscape. Is it time to panic, or is this a buying opportunity? We dive deep into the AI doomsday fears and how it could impact our portfolios. Plus:🧠 Axon’s stock-based comp problem: a great company, TERRIBLE stock? $AXON📊
We’re Taking Our Investors to Vegas — Here’s What We’re Betting On $NVDA $INV $CWEN (E125)
🎰 What happens when two investors hit Vegas with their Patreons? Craps strategies, poker tournaments, and a $50 bounty on Monkey’s scalp🧠 The one investing mistake almost everyone makes — and why borrowed conviction will cost you everything when the market turns🃏 Why poker pros keep becoming legendary investors —
Are You Investing in the Right Layer of AI? Jensen’s Blueprint for the Next Decade
🎂 Jensen’s Five-Layer AI Cake — NVIDIA’s CEO Jensen Huang lays out his framework for how AI is built, from energy and chips to infrastructure, models, and applications. What does this roadmap mean for investors, and are our portfolios actually aligned with the tidal wave?🌊 Catching the AI Tidal Wave
Do Your Stocks Own YOU? + Oddity Deep Dive, Gold vs Bitcoin & The End of US Exceptionalism?
Do your stocks own YOU — or do you own them? This week we tackle identity-driven investing, with a Thomas Chua quote that should make every investor uncomfortable.Monkey walks through his complete $ODD (Oddity Tech) investment process — from first nibble at $36, to options at the lows, to literally